Kata went to the American Society of Gene and Cell Therapy (ASGCT) yearly conference in Baltimore, USA. The meeting, the largest of its kind, focuses on novel translational findings in the field of gene and cell therapy, and this year attracted nearly 8000 scientists to join.

Kata’s poster (see below) was titled CRISPR/Cas9 T cell editing pipeline for monogenic primary immunodeficiency disorders. We were happy to see it received a lot of interest from our international colleagues. 😊